Headquartered in San Francisco, CA Fiscal year ends December NASDAQ: LIFE ethos.com
Ethos Technologies is a life insurance technology company that operates a three-sided digital platform connecting consumers, insurance agents, and carriers. The company offers instant, accessible life insurance products through a seamless online process that requires no medical exams and only a few health questions, eliminating traditional barriers to obtaining coverage. Ethos generates revenue through commissions on life insurance policies sold via its Direct Channel (consumer-facing online platform) and Third-Party Channel (agent partnerships). The company distributes products from multiple insurance carriers and underwrites policies using its proprietary technology stack. Ethos trades on Nasdaq under the ticker LIFE and recently completed an initial public offering. The company's product lineup includes term life, whole life, and indexed universal life (IUL) insurance, including a recently launched Juvenile IUL product. Updated
Pre-Market Stock Futures: Futures are trading higher after the bulls charged early Wednesday after the August CPE inflation report came in better than expected. But by the close, the tech-heavy Nasdaq was…
Pre-Market Stock Futures: Futures are trading lower as we start the trading week, with the fourth-quarter earnings season all but over and a slew of issues still clouding the horizon for stocks.…
Tuesday's top analyst upgrades, downgrades and initiations included Amgen, Beyond Meat, Cisco, Home Depot, Microsoft, RingCentral, Shake Shack, Tilray, Uber, Under Armour and U.S. Steel.
Trump said last week that companies in the health care sector are “getting away with murder,” and that something had to change. The sector has pulled back slightly since then, but there…
aTyr Pharma shares dropped early on Tuesday after the company announced clinical results from its exploratory trials assessing the safety and potential activity of Resolaris.
Chris Lange aTyr Pharma watched its shares climb early on Monday after the company announced that its product candidate Resolaris was granted Fast Track designation by the FDA.
Chris Lange April 8, 2016: Here are four stocks trading with relatively heavy volume among 22 equities making new 52-week lows in Friday’s session. The day’s NYSE winners led losers by about 3-to-1. The…
U.S. equity markets opened slightly higher this morning on another day when very little economic data was released anywhere around the globe. There was no data released at all in the U.S.,…
Jon OggInvestors often get to see the various analyst upgrades and Buy ratings issued by Wall Street firms. What investors often do not get to see is when analyst downgrade stocks to sell…
U.S. equity markets opened lower this morning as overnight trading in gold saw the beginnings of the biggest one-day drop in the yellow metal’s price in 30 years (more coverage here). Markets…
ThinkstockThe world’s second largest maker of laboratory equipment, Thermo Fisher Scientific Inc. (NYSE: TMO) has agree to acquire competitor Life Technologies Corp. (NASDAQ: LIFE) for $13.6 billion in cash ($76 a share).…
ThinkstockWells Fargo & Co. (NYSE: WFC) cuts the number of outside investment managers that its brokers can offer to clients. (Reuters) Thermo Fisher Scientific Inc. (NYSE: TMO) is likely to pay $13…
courtesy of Facebook Inc.The FBI begins review of the relationship between a KPMG partner and Herbalife Ltd. (NYSE: HLF). (Reuters) Problems with lithium ion batteries hurt the growth of companies that make…
Jon OggInvestors and active traders are always on the lookout for new ideas to generate profits. 24/7 Wall St. looks over research calls from all over to find great ideas. Many research-driven…
Jon OggInvestors and traders seem to constantly look for new good research-driven ideas for stocks to buy and for stocks to sell. Some of these come from independent research firms and some…
Ethos Technologies is a life insurance technology company that operates a three-sided digital platform connecting consumers, insurance agents, and carriers.
The Wall Street consensus 12-month price target for LIFE is $35.62.
